148 related articles for article (PubMed ID: 32273303)
1. Treatment of Allergic Asthma with Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 (
Youssef M; De Sanctis JB; Shah J; Dumut DC; Hajduch M; Naumova AK; Radzioch D
J Pharmacol Exp Ther; 2020 Jun; 373(3):476-487. PubMed ID: 32273303
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Optimized Treatment Protocol Using LAU-7b Formulation against Ovalbumin (OVA) and House Dust Mite (HDM) -Induced Allergic Asthma in Atopic Hyperresponsive A/J Mice.
Youssef M; De Sanctis JB; Kanagaratham C; Tao S; Ahmed E; Radzioch D
Pharm Res; 2020 Jan; 37(2):31. PubMed ID: 31915990
[TBL] [Abstract][Full Text] [Related]
3. Age-Dependent Progression in Lung Pathophysiology can be Prevented by Restoring Fatty Acid and Ceramide Imbalance in Cystic Fibrosis.
Youssef M; De Sanctis JB; Shah J; Dumut DC; Hajduch M; Petrof BJ; Radzioch D
Lung; 2020 Jun; 198(3):459-469. PubMed ID: 32306138
[TBL] [Abstract][Full Text] [Related]
4. Loss of the zona pellucida-binding protein 2 (Zpbp2) gene in mice impacts airway hypersensitivity and lung lipid metabolism in a sex-dependent fashion.
Kanagaratham C; Chiwara V; Ho B; Moussette S; Youssef M; Venuto D; Jeannotte L; Bourque G; de Sanctis JB; Radzioch D; Naumova AK
Mamm Genome; 2018 Apr; 29(3-4):281-298. PubMed ID: 29536159
[TBL] [Abstract][Full Text] [Related]
5. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside.
Garić D; De Sanctis JB; Wojewodka G; Houle D; Cupri S; Abu-Arish A; Hanrahan JW; Hajduch M; Matouk E; Radzioch D
J Mol Med (Berl); 2017 Oct; 95(10):1053-1064. PubMed ID: 28695226
[TBL] [Abstract][Full Text] [Related]
6. The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice.
Debeuf N; Zhakupova A; Steiner R; Van Gassen S; Deswarte K; Fayazpour F; Van Moorleghem J; Vergote K; Pavie B; Lemeire K; Hammad H; Hornemann T; Janssens S; Lambrecht BN
J Allergy Clin Immunol; 2019 Dec; 144(6):1648-1659.e9. PubMed ID: 31330218
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary delivery of ORMDL3 short hairpin RNA - a potential tool to regulate allergen-induced airway inflammation.
Dileepan M; Ha SG; Rastle-Simpson S; Ge XN; Greenberg YG; Wijesinghe DS; Contaifer D; Rao SP; Sriramarao P
Exp Lung Res; 2020 Sep; 46(7):243-257. PubMed ID: 32578458
[No Abstract] [Full Text] [Related]
8. Aberrant ORM (yeast)-like protein isoform 3 (ORMDL3) expression dysregulates ceramide homeostasis in cells and ceramide exacerbates allergic asthma in mice.
Oyeniran C; Sturgill JL; Hait NC; Huang WC; Avni D; Maceyka M; Newton J; Allegood JC; Montpetit A; Conrad DH; Milstien S; Spiegel S
J Allergy Clin Immunol; 2015 Oct; 136(4):1035-46.e6. PubMed ID: 25842287
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids, ORMDL3 and asthma: what is the evidence?
Worgall TS
Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):99-103. PubMed ID: 28030368
[TBL] [Abstract][Full Text] [Related]
10. Regulatory interaction between the ZPBP2-ORMDL3/Zpbp2-Ormdl3 region and the circadian clock.
Chang ML; Moussette S; Gamero-Estevez E; Gálvez JH; Chiwara V; Gupta IR; Ryan AK; Naumova AK
PLoS One; 2019; 14(9):e0223212. PubMed ID: 31560728
[TBL] [Abstract][Full Text] [Related]
11. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
12. Ceramide Imbalance and Impaired TLR4-Mediated Autophagy in BMDM of an ORMDL3-Overexpressing Mouse Model.
Kiefer K; Casas J; García-López R; Vicente R
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897694
[TBL] [Abstract][Full Text] [Related]
13. IκBNS induces Muc5ac expression in epithelial cells and causes airway hyper-responsiveness in murine asthma models.
Yokota M; Tamachi T; Yokoyama Y; Maezawa Y; Takatori H; Suto A; Suzuki K; Hirose K; Takeda K; Nakajima H
Allergy; 2017 Jul; 72(7):1043-1053. PubMed ID: 27878831
[TBL] [Abstract][Full Text] [Related]
14. IRAK-M knockout promotes allergic airway inflammation, but not airway hyperresponsiveness, in house dust mite-induced experimental asthma model.
Zhang X; Zhang M; Li L; Chen W; Zhou W; Gao J
J Thorac Dis; 2021 Mar; 13(3):1413-1426. PubMed ID: 33841934
[TBL] [Abstract][Full Text] [Related]
15. ORMDL3 expression levels have no influence on the activity of serine palmitoyltransferase.
Zhakupova A; Debeuf N; Krols M; Toussaint W; Vanhoutte L; Alecu I; Kutalik Z; Vollenweider P; Ernst D; von Eckardstein A; Lambrecht BN; Janssens S; Hornemann T
FASEB J; 2016 Dec; 30(12):4289-4300. PubMed ID: 27645259
[TBL] [Abstract][Full Text] [Related]
16. ORMDL/serine palmitoyltransferase stoichiometry determines effects of ORMDL3 expression on sphingolipid biosynthesis.
Siow D; Sunkara M; Dunn TM; Morris AJ; Wattenberg B
J Lipid Res; 2015 Apr; 56(4):898-908. PubMed ID: 25691431
[TBL] [Abstract][Full Text] [Related]
17. Cutting Edge: Targeting Epithelial ORMDL3 Increases, Rather than Reduces, Airway Responsiveness and Is Associated with Increased Sphingosine-1-Phosphate.
Miller M; Tam AB; Mueller JL; Rosenthal P; Beppu A; Gordillo R; McGeough MD; Vuong C; Doherty TA; Hoffman HM; Niwa M; Broide DH
J Immunol; 2017 Apr; 198(8):3017-3022. PubMed ID: 28275141
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 deletion of ORMDLs reveals complexity in sphingolipid metabolism.
Green CD; Weigel C; Oyeniran C; James BN; Davis D; Mahawar U; Newton J; Wattenberg BW; Maceyka M; Spiegel S
J Lipid Res; 2021; 62():100082. PubMed ID: 33939982
[TBL] [Abstract][Full Text] [Related]
19. Role of DNA methylation in expression control of the IKZF3-GSDMA region in human epithelial cells.
Moussette S; Al Tuwaijri A; Kohan-Ghadr HR; Elzein S; Farias R; Bérubé J; Ho B; Laprise C; Goodyer CG; Rousseau S; Naumova AK
PLoS One; 2017; 12(2):e0172707. PubMed ID: 28241063
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory innate defence regulator (IDR) peptide alleviates airway inflammation and hyper-responsiveness.
Piyadasa H; Hemshekhar M; Altieri A; Basu S; van der Does AM; Halayko AJ; Hiemstra PS; Mookherjee N
Thorax; 2018 Oct; 73(10):908-917. PubMed ID: 29853649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
